Strategic Blueprint LLC Sells 1,000 Shares of CymaBay Therapeutics, Inc. (NASDAQ:CBAY)
Strategic Blueprint LLC cut its stake in CymaBay Therapeutics, Inc. (NASDAQ:CBAY – Free Report) by 6.0% in the fourth quarter, HoldingsChannel.com reports. The fund owned 15,800 shares of the biopharmaceutical company’s stock after selling 1,000 shares during the period. Strategic Blueprint LLC’s holdings in CymaBay Therapeutics were worth $373,000 at the end of the most […]
More Stories
Hochschild Mining (LON:HOC) Stock Price Crosses Above 200 Day Moving Average – Time to Sell?
Hochschild Mining plc (LON:HOC – Get Free Report)’s share price passed above its two hundred day moving average during trading...
Tortoise Pipeline & Energy Fund (NYSE:TTP) Shares Pass Above 200 Day Moving Average – Time to Sell?
Tortoise Pipeline & Energy Fund, Inc. (NYSE:TTP – Get Free Report) shares crossed above its 200-day moving average during trading...
K-Bro Linen (TSE:KBL) Stock Price Passes Above 200-Day Moving Average – Should You Sell?
K-Bro Linen Inc. (TSE:KBL – Get Free Report)’s stock price passed above its 200-day moving average during trading on Thursday...
Rep. Lloyd Doggett Purchases Shares of The Coca-Cola Company (NYSE:KO)
Representative Lloyd Doggett (D-Texas) recently bought shares of The Coca-Cola Company (NYSE:KO). In a filing disclosed on January 08th, the...
Seres Therapeutics Provides Corporate Updates and Financial Results
On January 9, 2025, Seres Therapeutics, Inc. (NASDAQ: MCRB) released significant updates regarding its recent achievements and financial standing. The...
Cohort (LON:CHRT) Stock Price Crosses Above 200-Day Moving Average – Here’s Why
Shares of Cohort plc (LON:CHRT – Get Free Report) crossed above its 200-day moving average during trading on Thursday ....